Gossamer Bio Debt-to-Equity Ratio Growth & History (GOSS)

Gossamer Bio's debt-to-equity ratio was 0.18 for fiscal 2024.

View full Gossamer Bio company overview

Gossamer Bio annual debt-to-equity ratio history

Gossamer Bio annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20242024-12-310.18−0.07−28.14%
20232023-12-310.25−2.23−89.83%
20222022-12-312.492.20+758.04%
20212021-12-310.290.16+131.81%
20202020-12-310.130.01+11.42%
20192019-12-310.11

Gossamer Bio debt-to-equity ratio trends

Over the last five fiscal years, Gossamer Bio's debt-to-equity ratio increased from 0.11 to 0.18, a change of 0.07. The latest reported quarter, Q4 2024, shows 0.18.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Gossamer Bio source filings ↗

Community posts

It’s quiet here.

No posts about GOSS yet. Start the conversation.

Write the first post